Creekmur Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$16.6K Hold
150
﹤0.01% 463
2025
Q2
$16.6K Hold
150
﹤0.01% 461
2025
Q1
$16.8K Hold
150
﹤0.01% 422
2024
Q4
$13.9K Hold
150
﹤0.01% 383
2024
Q3
$12.6K Hold
150
﹤0.01% 412
2024
Q2
$10.3K Sell
150
-25
-14% -$1.67K ﹤0.01% 500
2024
Q1
$12.8K Buy
175
+25
+17% +$1.92K ﹤0.01% 450
2023
Q4
$12.2K Buy
+150
New +$11.7K ﹤0.01% 507

Other funds holding GILD

Creekmur Asset Management's GILD Position: Q3 2025 in Review

Creekmur Asset Management held its Gilead Sciences (GILD) position steady in Q3 2025 at 150 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Creekmur Asset Management first reported a position in GILD in Q4 2023 and has held it in 8 quarters since. The position peaked at $16.8K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Creekmur Asset Management held 150 shares of Gilead Sciences worth $16.6K as of Q3 2025.
  • Creekmur Asset Management left its Gilead Sciences share count unchanged in Q3 2025.
  • Gilead Sciences made up ﹤0.01% of Creekmur Asset Management's portfolio in Q3 2025, its #463 holding.
  • Creekmur Asset Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 8 quarters since.
  • Creekmur Asset Management's Gilead Sciences position peaked at $16.8K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Creekmur Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.